Rituximab (Rituxan)

DRUG2 trials

Sponsors

University of Vermont, Pfizer

Conditions

Lymphoma, B-CellRefractory Myasthenia Gravis

Phase 1

A Pilot Trial of Rituxan in Refractory Myasthenia Gravis

CompletedNCT00619671

University of VermontRefractory Myasthenia Gravis

Start: 2004-04-30End: 2009-03-31Target: 10Updated: 2013-01-16

Study Evaluating The Safety And Tolerability Of Combination Therapy Inotuzumab Ozogamicin (CMC-544) And Rituximab

CompletedNCT00724971

PfizerLymphoma, B-Cell

Start: 2008-07-04End: 2010-03-10Updated: 2019-03-15

Related Papers

Phase I study of anti-CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B-cell non-Hodgkin lymphoma.

2012-03-2050 citations